AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
The podcast delves into the FDA's decision to allow Florida to import drugs from Canada and discusses the differences in drug prices between the US and Canada. It also explores ethical dilemmas in global markets, the importance of transparency in drug pricing, and cybersecurity preparedness for finance leaders.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- US drug prices are much higher than in Canada due to lack of pricing mechanisms. Pharmacy benefit managers profit from negotiating rebates, driving up costs.
- Importing drugs from Canada poses challenges due to market size differences. Shortages in both countries complicate reliance on Canada's drug market.
Deep dives
Rising Drug Prices in the US vs. Canada
Dr. Mariana Socal discusses how drug prices in the US are three to four times higher than in Canada, even for long-standing drugs. The lack of pricing mechanisms in the US allows for continuous price increases, often unsupported by changes in the drugs. Additionally, US entities like pharmacy benefit managers profit from negotiating rebates, leading to higher drug costs.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode